e.lehtinen

TL2 · Curitiba

Contributes reviews on supplier material. Based in Curitiba.

Joined 16 January 2025 · last posted 2d · groups: regional-apac

83Posts here

1Topics

0Solutions

1.6kLikes received

1.6kLikes given

22Badges

214Days visited

5.3kPosts read

Recent activity

Full stream

Ultrasound and skinfolds: operator dependence in practice Replied, post #77 · Outcomes › Body composition · 26 Jul 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #84 · Practice › Interactions · 24 Jul 2026 · 1 like Practical note on Antibiotics: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #78 · Outcomes › Progress reports · 20 Jul 2026 · 1 like Comparing your trajectory to a trial mean is comparing an individual to an average of a selected population, and the spread around that mean is wide. I would not lead a…
Follow-up: How compounding permissions changed when supply normalised Replied, post #42 · Sourcing › Regulatory · 19 Jul 2026 · 6 likes An update on my earlier compounding permissions post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #110 · Evidence › Preprints · 19 Jul 2026 · 0 likes This follows post #109 rather than contradicting it. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi.…
Alcohol: what is documented and what is folklore Replied, post #118 · Practice › Interactions · 18 Jul 2026 · 0 likes I had written a reply contradicting post #114 and deleted it. Here is what survived. The most defensible general position in this subcategory: identify the plausible…
Athletes in weight-category sports: a different risk calculus Replied, post #21 · Clinical › Special populations · 11 Jul 2026 · 24 likes A methods point on athletes in weight-category sports rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
What to bring: records that a clinician can actually use — a second dataset Replied, post #16 · Clinical › Prescriber conversations · 8 Jul 2026 · 0 likes Where you have a specific worry, name it. "I am worried about X" is more useful to a clinician than a series of questions circling X. The short answer was in the first…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #59 · Access › Insurance & coverage · 7 Jul 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #63 · Sourcing › Independent verification · 4 Jul 2026 · 30 likes The arithmetic in post #60 is right; the assumption feeding it is the part to check. The question underneath Interpreting a result is usually "how would I tell?" rather…
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #5 · Pharmacology › Receptor biology · 30 Jun 2026 · 1 like Narrowing post #4, because the general version has more than one answer. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion),…
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #28 · Compounds › Semaglutide · 26 Jun 2026 · 21 likes Picking up post #27: that is the part I would want checked first. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they…